Global Platelet Rich Plasma Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1348

Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration.PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel.
In 2018, the global Platelet Rich Plasma market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Platelet Rich Plasma status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Platelet Rich Plasma development in United States, Europe and China.

The key players covered in this study
AdiStem Ltd.
Arthrex, Inc.
Biomet, Inc.
Cesca Therapeutics, Inc.
DePuy Synthes, Inc.
EmCyte Corporation
Exactech, Inc.
Harvest Technologies Corp.
Nuo Therapeutics, Inc.
Regen Lab SA
Stryker Corporation

Market segment by Type, the product can be split into
Pure PRP
Leukocyte-Rich PRP
Leukocyte-Rich Fibrin

Market segment by Application, split into
Orthopedics
Cosmetic Surgery & Dermatology
Ophthalmic Surgery
Neurosurgery
General surgery
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Platelet Rich Plasma status, future forecast, growth opportunity, key market and key players.
To present the Platelet Rich Plasma development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Platelet Rich Plasma are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Platelet Rich Plasma Market Size Growth Rate by Type (2014-2025)
1.4.2 Pure PRP
1.4.3 Leukocyte-Rich PRP
1.4.4 Leukocyte-Rich Fibrin
1.5 Market by Application
1.5.1 Global Platelet Rich Plasma Market Share by Application (2014-2025)
1.5.2 Orthopedics
1.5.3 Cosmetic Surgery & Dermatology
1.5.4 Ophthalmic Surgery
1.5.5 Neurosurgery
1.5.6 General surgery
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Platelet Rich Plasma Market Size
2.2 Platelet Rich Plasma Growth Trends by Regions
2.2.1 Platelet Rich Plasma Market Size by Regions (2014-2025)
2.2.2 Platelet Rich Plasma Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Platelet Rich Plasma Market Size by Manufacturers
3.1.1 Global Platelet Rich Plasma Revenue by Manufacturers (2014-2019)
3.1.2 Global Platelet Rich Plasma Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Platelet Rich Plasma Market Concentration Ratio (CR5 and HHI)
3.2 Platelet Rich Plasma Key Players Head office and Area Served
3.3 Key Players Platelet Rich Plasma Product/Solution/Service
3.4 Date of Enter into Platelet Rich Plasma Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Platelet Rich Plasma Market Size by Type (2014-2019)
4.2 Global Platelet Rich Plasma Market Size by Application (2014-2019)

5 United States
5.1 United States Platelet Rich Plasma Market Size (2014-2019)
5.2 Platelet Rich Plasma Key Players in United States
5.3 United States Platelet Rich Plasma Market Size by Type
5.4 United States Platelet Rich Plasma Market Size by Application

6 Europe
6.1 Europe Platelet Rich Plasma Market Size (2014-2019)
6.2 Platelet Rich Plasma Key Players in Europe
6.3 Europe Platelet Rich Plasma Market Size by Type
6.4 Europe Platelet Rich Plasma Market Size by Application

7 China
7.1 China Platelet Rich Plasma Market Size (2014-2019)
7.2 Platelet Rich Plasma Key Players in China
7.3 China Platelet Rich Plasma Market Size by Type
7.4 China Platelet Rich Plasma Market Size by Application

8 Japan
8.1 Japan Platelet Rich Plasma Market Size (2014-2019)
8.2 Platelet Rich Plasma Key Players in Japan
8.3 Japan Platelet Rich Plasma Market Size by Type
8.4 Japan Platelet Rich Plasma Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Platelet Rich Plasma Market Size (2014-2019)
9.2 Platelet Rich Plasma Key Players in Southeast Asia
9.3 Southeast Asia Platelet Rich Plasma Market Size by Type
9.4 Southeast Asia Platelet Rich Plasma Market Size by Application

10 India
10.1 India Platelet Rich Plasma Market Size (2014-2019)
10.2 Platelet Rich Plasma Key Players in India
10.3 India Platelet Rich Plasma Market Size by Type
10.4 India Platelet Rich Plasma Market Size by Application

11 Central & South America
11.1 Central & South America Platelet Rich Plasma Market Size (2014-2019)
11.2 Platelet Rich Plasma Key Players in Central & South America
11.3 Central & South America Platelet Rich Plasma Market Size by Type
11.4 Central & South America Platelet Rich Plasma Market Size by Application

12 International Players Profiles
12.1 AdiStem Ltd.
12.1.1 AdiStem Ltd. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Platelet Rich Plasma Introduction
12.1.4 AdiStem Ltd. Revenue in Platelet Rich Plasma Business (2014-2019)
12.1.5 AdiStem Ltd. Recent Development
12.2 Arthrex, Inc.
12.2.1 Arthrex, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Platelet Rich Plasma Introduction
12.2.4 Arthrex, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
12.2.5 Arthrex, Inc. Recent Development
12.3 Biomet, Inc.
12.3.1 Biomet, Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Platelet Rich Plasma Introduction
12.3.4 Biomet, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
12.3.5 Biomet, Inc. Recent Development
12.4 Cesca Therapeutics, Inc.
12.4.1 Cesca Therapeutics, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Platelet Rich Plasma Introduction
12.4.4 Cesca Therapeutics, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
12.4.5 Cesca Therapeutics, Inc. Recent Development
12.5 DePuy Synthes, Inc.
12.5.1 DePuy Synthes, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Platelet Rich Plasma Introduction
12.5.4 DePuy Synthes, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
12.5.5 DePuy Synthes, Inc. Recent Development
12.6 EmCyte Corporation
12.6.1 EmCyte Corporation Company Details
12.6.2 Company Description and Business Overview
12.6.3 Platelet Rich Plasma Introduction
12.6.4 EmCyte Corporation Revenue in Platelet Rich Plasma Business (2014-2019)
12.6.5 EmCyte Corporation Recent Development
12.7 Exactech, Inc.
12.7.1 Exactech, Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Platelet Rich Plasma Introduction
12.7.4 Exactech, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
12.7.5 Exactech, Inc. Recent Development
12.8 Harvest Technologies Corp.
12.8.1 Harvest Technologies Corp. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Platelet Rich Plasma Introduction
12.8.4 Harvest Technologies Corp. Revenue in Platelet Rich Plasma Business (2014-2019)
12.8.5 Harvest Technologies Corp. Recent Development
12.9 Nuo Therapeutics, Inc.
12.9.1 Nuo Therapeutics, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Platelet Rich Plasma Introduction
12.9.4 Nuo Therapeutics, Inc. Revenue in Platelet Rich Plasma Business (2014-2019)
12.9.5 Nuo Therapeutics, Inc. Recent Development
12.10 Regen Lab SA
12.10.1 Regen Lab SA Company Details
12.10.2 Company Description and Business Overview
12.10.3 Platelet Rich Plasma Introduction
12.10.4 Regen Lab SA Revenue in Platelet Rich Plasma Business (2014-2019)
12.10.5 Regen Lab SA Recent Development
12.11 Stryker Corporation

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details